Arvinas (ARVN) EBT (2017 - 2026)
Arvinas (ARVN) recorded quarterly EBT of -$57.5 million in Q1 2026, up 14.43% quarter-over-quarter from -$67.2 million in Q4 2025, and down 169.19% on a YoY basis from $83.1 million in Q1 2025.
Arvinas (ARVN) EBT (2017 - 2026) Analysis & Trends
Arvinas' EBT history runs 10 years deep, the most recent figure standing at -$57.5 million for Q1 2026.
- In Q1 2026, EBT fell 169.19% year-over-year to -$57.5 million; the TTM figure through Mar 2026 stood at -$221.0 million (down 380.43% YoY), while the FY2025 annual figure was -$80.5 million, up 59.4% from the prior year.
- EBT was -$57.5 million for Q1 2026 at Arvinas, up from -$67.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $83.1 million in Q1 2025 to a low of -$153.2 million in Q4 2023.
- Historically, EBT has averaged -$56.0 million across 5 years, with a median of -$61.5 million in 2025.
- The sharpest annual moves came in 2025 and 2026: EBT surged 219.91% in 2025, then plunged 169.19% in 2026.
- A 5-year view of EBT shows it stood at -$69.3 million in 2022, then plunged by 121.07% to -$153.2 million in 2023, then soared by 70.3% to -$45.5 million in 2024, then tumbled by 47.69% to -$67.2 million in 2025, then grew by 14.43% to -$57.5 million in 2026.
- The last three EBT figures came in at -$57.5 million (Q1 2026), -$67.2 million (Q4 2025), and -$34.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | -57.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.50 Mn |
| Dec 31, 2025 | -67.20 Mn |
| Sep 30, 2025 | -34.80 Mn |
| Jun 30, 2025 | -61.50 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Dec 31, 2024 | -45.50 Mn |
| Sep 30, 2024 | -48.60 Mn |
| Jun 30, 2024 | -35.00 Mn |
| Mar 31, 2024 | -69.30 Mn |
| Dec 31, 2023 | -153.20 Mn |
| Sep 30, 2023 | -63.90 Mn |
| Jun 30, 2023 | -65.60 Mn |
| Mar 31, 2023 | -81.20 Mn |
| Dec 31, 2022 | -69.30 Mn |
| Sep 30, 2022 | -61.10 Mn |
| Jun 30, 2022 | -64.10 Mn |
| Mar 31, 2022 | -56.60 Mn |
| Dec 31, 2021 | -46.10 Mn |
| Sep 30, 2021 | -46.80 Mn |
| Jun 30, 2021 | -50.30 Mn |